GlassScriptPhysician profile
Dana S Salgado
NPI 1487666251
$119,339.42
in general payments reported to CMS, 2019-2025
13 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,678 · 2020: $7,843 · 2021: $6,742 · 2022: $6,619 · 2023: $6,339 · 2024: $67K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $69K · Travel and Lodging: $19K · Food and Beverage: $5,180 · Consulting Fee: $1,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $69,475.00 |
| Travel and Lodging | $19,282.70 |
| Food and Beverage | $5,179.97 |
| Consulting Fee | $1,520.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $101,304.57 | 2022-2025 | Infuse, Infuse Multifocal, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15,877.88 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $1,036.40 | 2019 | |
| Sight Sciences, INC. | $272.98 | 2023 | Omni Surgical System |
| Glaukos Corporation | $258.11 | 2021-2023 | |
| Astellas Pharma US INC | $115.20 | 2023 | |
| Alcon Vision LLC | $114.83 | 2025 | Clareon Panoptix Pro |
| Allergan, INC. | $108.80 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $78.69 | 2019 | |
| Visioneering Technologies, INC. | $67.95 | 2019 | |
| Lkc Technologies, INC. | $66.77 | 2022 | |
| Coopervision INC. | $20.00 | 2025 | Misight Contact Lens |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Salgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.